The New York Times reports that a Maryland psychiatrist, Dr. Peter Gleason, was handcuffed and arrested in March and charged with criminal promotion of a drug "for purposes other than those approved by the federal government."
Bloomberg News reports (below) that Senator Charles Grassley has asked the Inspector General to investigate collusion between FDA officials and Merck. Citing handwritten notes prepared by a Merck executive document a meeting with FDA division director, Brian Harvey, suggesting a joint effort "to get the message out" to discredit Dr….
The Associated Press reports (1, 2 below) that the FDA has just issued new warnings about two additional life-threatening risks induced by SSRI antidepressants: Serotonin Syndrome and Persistent Pulmonary Hypertension in newborn babies.
The Wall Street Journal and Bloomberg News report about a case involving Neuropsychopharmacology, the official journal of the American College of Neuropsychopharmacology (ACNP) that will likely go down in history as psychiatry’s Watergate.
New Peer-Reviewed Publication Authored By Leading Scientists Provides Comprehensive Review of VNS Therapy Mechanism of Action in Treatment-Resistant Depression
CYBERONICS ANNOUNCES MECHANISM OF ACTION ADVISORY BOARD
Operating like thieves under the cover of darkness, prominent academic-based "authorities" in medical specialties have debased academic standards and sold their reputations for cash-
The latest investigative report focusing on financial conflicts of interest by Pulitzer Prize winner, David Willman of the Los Angeles Times, reveals that even as the NIH director, Dr. Elias Zerhouni, announced publicly last year that scientists at the National Institutes of Health would be barred from accepting consulting fees from industry, evidence shows that the ban is clearly not being enforced.
A front page article in The New York Times reports: "The breakfast buffet at Camp Echo starts at a picnic table covered in gingham-patterned oil cloth.
Three essays provide an overview of the bias that has debased the integrity of medical research literature while increasing the hazards of medical practice–for patients and doctors who are kept in the dark about prescribed treatment dangers.
Two probing first rate investigative reports document how psychiatry’s treatments are shaped by "opinion leaders" whose professional recommendations are compromised by their substantial, largely undisclosed, financial ties to drug companies.
An investigative report in Mercury News (below) focuses on Stanford University department heads, associate deans and other leaders because “these are senior people who set the tone at the medical school and are role models for junior faculty members.”
